Roche NimbleGen to Expand CGH Array Menu, Plans Additional High-Density Chips

The new high-density chips could give Roche NimbleGen an advantage in the market for clinical research arrays, such as cytogenetics, where it competes against Affymetrix, Agilent Technologies, and Illumina.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.